The Latest Cardiac and Vascular News
BEDFORD, Mass., Aug. 15, 2023 /PRNewswire/ — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the closing of a $30 million financing round. This financing round was led by new investor, Delos Capital, with continued participation from the investor syndicate of Excelestar Ventures, Ascension Ventures, Catalyst Health […]
DENVER, June 29, 2021 /PRNewswire/ — Dr. Charles Nutting, DO FSIR and ECCO Medical, the leading endovascular treatment center in Colorado, are pleased to announce their participation in the Embrace™ Hydrogel Embolic System (HES) global randomized clinical trial for the treatment of hypervascular tumors. The study is sponsored by Instylla, Inc. and focuses on […]
